{"id":515572,"date":"2021-07-21T08:03:14","date_gmt":"2021-07-21T12:03:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/"},"modified":"2021-07-21T08:03:14","modified_gmt":"2021-07-21T12:03:14","slug":"celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/","title":{"rendered":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site<\/b><\/p>\n<p class=\"bwalignc\"><i>State-of-the-art R&amp;D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides<\/i><\/p>\n<p>DALLAS &amp; FLORENCE, Ky.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCelanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced an expansion of its Florence, Kentucky research and development center with the addition of a <i>Pharmaceutical Drug Delivery Feasibility Lab<\/i>. The new feasibility lab will drive new development for long-acting controlled release drug delivery. This represents a significant investment and commitment to the Pharmaceutical segment of Celanese\u2019s engineered materials business. The feasibility lab expands pharmaceutical companies\u2019 access to highly customized materials and service solutions.\n<\/p>\n<p>\nThe new Florence pharmaceutical feasibility lab enables Celanese to accelerate customers\u2019 development projects for long-acting delivery of small molecules, biologics and RNA. Services include material characterization; injection molding, hot-melt extrusion, and other prototyping capabilities; monolithic or multi-layer drug-loaded prototypes; in vitro characterization and drug release studies; and tooling design and development.\n<\/p>\n<p>\n\u201cWhen Celanese works with pharmaceutical customers, we first seek to understand their design challenges and identify factors that are critical to quality,\u201d noted Jeff Haley, Senior Manager and Product Specialist, Pharmaceutical Development for Celanese. \u201cWe then assemble the right team of experts, select the right tool set, and develop a program plan to help solve their materials challenges. Technical or materials requirements vary by customer, and Celanese is here to offer targeted solutions to ensure our customers can quickly bring to market a successful product that has a meaningful impact on patient health and quality of life.\u201d\n<\/p>\n<p>\nCelanese offers cutting-edge medical and pharmaceutical material solutions and expert development support to Medical Device and Pharmaceutical companies worldwide. With more than 40 years of experience supporting key applications and the demanding requirements of the medical market, Celanese is expanding design possibilities as our customers find new ways to deliver a sustained dose of medication over time. The Company\u2019s continuously expanding Medical Technology\u00ae portfolio includes solutions and technologies for applications across drug delivery, medical devices, orthopedics, advanced surgical instruments and connected devices. For more information on healthcare-specific product features and benefits, visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhealthcare.celanese.com%2Fproducts-and-solutions%2Fvitaldose&amp;esheet=52463073&amp;newsitemid=20210721005088&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhealthcare.celanese.com%2Fproducts-and-solutions%2Fvitaldose&amp;index=1&amp;md5=5feef4f166fe5e8005af8dd9da0bde97\">https:\/\/healthcare.celanese.com\/products-and-solutions\/vitaldose<\/a><\/p>\n<p><b>Product Availability &amp; Contacts<\/b><\/p>\n<p>\nTo discuss solutions for long-acting delivery of small molecules, biologics and RNA, contact a Celanese commercial representative via <a rel=\"nofollow\" href=\"mailto:Healthcare@Celanese.com\">Healthcare@Celanese.com<\/a>. To learn more about Celanese healthcare solutions, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhealthcare.celanese.com%2F&amp;esheet=52463073&amp;newsitemid=20210721005088&amp;lan=en-US&amp;anchor=healthcare.celanese.com&amp;index=2&amp;md5=8e4740eaed5d23f389e46f4ade6dd626\">healthcare.celanese.com<\/a>.\n<\/p>\n<p><b><i>About Celanese<\/i><\/b><\/p>\n<p><i>Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese&#8217;s global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2020 net sales of $5.7 billion. For more information about Celanese Corporation and its product offerings, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.celanese.com&amp;esheet=52463073&amp;newsitemid=20210721005088&amp;lan=en-US&amp;anchor=www.celanese.com&amp;index=3&amp;md5=bfaa57c429e5d0ce837455db78183f56\">www.celanese.com<\/a> or our blog at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.celaneseblog.com&amp;esheet=52463073&amp;newsitemid=20210721005088&amp;lan=en-US&amp;anchor=www.celaneseblog.com&amp;index=4&amp;md5=e756ee92659331404abd98825ae7fba4\">www.celaneseblog.com<\/a><\/i>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210721005088\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210721005088\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations<br \/>\n<\/b><br \/>Brandon Ayache<br \/>\n<br \/>+1 972 443 8509<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:brandon.ayache@celanese.com\">brandon.ayache@celanese.com<\/a><\/p>\n<p><b>Media Relations \u2013 Global<br \/>\n<\/b><br \/>W. Travis Jacobsen<br \/>\n<br \/>+1 972 443 3750<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:william.jacobsen@celanese.com\">william.jacobsen@celanese.com<\/a><\/p>\n<p><b>Media Relations Europe (Germany)<br \/>\n<\/b><br \/>Petra Czugler<br \/>\n<br \/>+49 69 45009 1206<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:petra.czugler@celanese.com\">petra.czugler@celanese.com<\/a><span class=\"bwuline\" \/><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas Kentucky<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Health Research Pharmaceutical Medical Devices Other Manufacturing Clinical Trials Science Chemicals\/Plastics Medical Supplies FDA Manufacturing Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210721005088\/en\/385443\/3\/Celanese-tag_rgb.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site State-of-the-art R&amp;D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides DALLAS &amp; FLORENCE, Ky.&#8211;(BUSINESS WIRE)&#8211; Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced an expansion of its Florence, Kentucky research and development center with the addition of a Pharmaceutical Drug Delivery Feasibility Lab. The new feasibility lab will drive new development for long-acting controlled release drug delivery. This represents a significant investment and commitment to the Pharmaceutical segment of Celanese\u2019s engineered materials business. The feasibility lab expands pharmaceutical companies\u2019 access to highly customized materials and service solutions. The new Florence pharmaceutical feasibility lab enables Celanese to accelerate customers\u2019 development &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515572","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site State-of-the-art R&amp;D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides DALLAS &amp; FLORENCE, Ky.&#8211;(BUSINESS WIRE)&#8211; Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced an expansion of its Florence, Kentucky research and development center with the addition of a Pharmaceutical Drug Delivery Feasibility Lab. The new feasibility lab will drive new development for long-acting controlled release drug delivery. This represents a significant investment and commitment to the Pharmaceutical segment of Celanese\u2019s engineered materials business. The feasibility lab expands pharmaceutical companies\u2019 access to highly customized materials and service solutions. The new Florence pharmaceutical feasibility lab enables Celanese to accelerate customers\u2019 development &hellip; Continue reading &quot;Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-21T12:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site\",\"datePublished\":\"2021-07-21T12:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/\"},\"wordCount\":594,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/\",\"name\":\"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-07-21T12:03:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/","og_locale":"en_US","og_type":"article","og_title":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site - Market Newsdesk","og_description":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site State-of-the-art R&amp;D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides DALLAS &amp; FLORENCE, Ky.&#8211;(BUSINESS WIRE)&#8211; Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced an expansion of its Florence, Kentucky research and development center with the addition of a Pharmaceutical Drug Delivery Feasibility Lab. The new feasibility lab will drive new development for long-acting controlled release drug delivery. This represents a significant investment and commitment to the Pharmaceutical segment of Celanese\u2019s engineered materials business. The feasibility lab expands pharmaceutical companies\u2019 access to highly customized materials and service solutions. The new Florence pharmaceutical feasibility lab enables Celanese to accelerate customers\u2019 development &hellip; Continue reading \"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-21T12:03:14+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site","datePublished":"2021-07-21T12:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/"},"wordCount":594,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/","name":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-07-21T12:03:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210721005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celanese-opens-pharmaceutical-drug-delivery-feasibility-lab-at-florence-kentucky-site\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515572"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515572\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}